NICE recommends weekly injection for severe haemophilia B

The National Institute for Health and Care Excellence (NICE) has recommended a weekly injection to treat severe haemophilia B for use on the NHS in England. In final guidance, published on 24 June 2025, NICE approved marstacimab (Hympavzi; Pfizer) for patients with severe haemophilia B — which involves people having less than 1% of the […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.362237
Primary Topic: Hemophilia Treatment and Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

NICE recommends weekly injection for severe haemophilia B

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Hemophilia Treatment and Research

article

NICE recommends weekly injection for severe haemophilia B

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Openalex Percentile: Top 81%

Hemophilia Treatment and Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

NICE recommends weekly injection for severe haemophilia B · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS